Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: Immunopathological findings and clinical experience in 10 Dutch patients

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 815-822

  Terra, J B ^a   Pas, H H ^a   Hertl, M ^b   Dikkers, F G ^c   Kamminga, N ^a   Jonkman, M F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Departments of Otorhinolaryngology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DAPSONE; DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LAMININ 332 AUTOANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONJUNCTIVITIS; DERMATOLOGICAL PROCEDURES; DRUG PULSE THERAPY; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOLOGICAL TECHNIQUE; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; LARYNX DISORDER; LUNG ADENOCARCINOMA; MALE; MOUTH LESION; MUCOUS MEMBRANE PEMPHIGOID; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; SERRATION PATTERN ANALYSIS; SYMBLEPHARON;

ADULT; AGED; ALGORITHMS; AUTOANTIBODIES; CELL ADHESION MOLECULES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE;

EID: 80053563510     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10474.x     Document Type: Article

References (43)

1. Domloge-Hultsch N, Gammon WR, Briggaman RA, et al. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992; 90: 1628-33.
2. Aumailley M, Bruckner-Tuderman L, Carter WG, et al. A simplified laminin nomenclature. Matrix Biol 2005; 24: 326-32. (Pubitemid 41021635)
3. Niessen CM, Hogervorst F, Jaspars LH, et al. The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 1994; 211: 360-7.
4. Rousselle P, Keene DR, Ruggiero F, et al. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol 1997; 138: 719-28. (Pubitemid 27349850)
5. Egan CA, Lazarova Z, Darling TN, et al. Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations. Medicine (Baltimore) 2003; 82: 177-86. (Pubitemid 36578707)
6. Dainichi T, Takeshita H, Moroi Y, et al. Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit. Eur J Dermatol 2005; 15: 189-93. (Pubitemid 40733429)
7. Chan LS, Majmudar AA, Tran HH, et al. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 1997; 108: 848-53. (Pubitemid 27272397)
8. Allbritton JI, Nousari HC, Anhalt GJ,. Anti-epiligrin (laminin 5) cicatricial pemphigoid. Br J Dermatol 1997; 137: 992-6. (Pubitemid 28011146)
9. Benoit S, Schmidt E, Sitaru C, et al. [Anti-laminin 5 mucous membrane pemphigoid]. J Dtsch Dermatol Ges 2006; 4: 41-4.
10. Hsu RC, Lazarova Z, Lee HG, et al. Antiepiligrin cicatricial pemphigoid. J Am Acad Dermatol 2000; 42: 841-4. (Pubitemid 30252896)
11. Lish KM, Washenik K, Yancey KB, et al. Anti-epiligrin cicatricial pemphigoid in a patient with HIV. J Am Acad Dermatol 1997; 36: 486-8. (Pubitemid 27131982)
12. Leverkus M, Schmidt E, Lazarova Z, et al. Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 1999; 135: 1091-8. (Pubitemid 29430500)
13. Sadler E, Lazarova Z, Sarasombath P, et al. A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer. J Dermatol Sci 2007; 47: 1-7. (Pubitemid 46756210)
14. Fujimoto W, Ishida-Yamamoto A, Hsu R, et al. Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. Br J Dermatol 1998; 139: 682-7. (Pubitemid 28474318)
15. Fukushima S, Egawa K, Nishi H, et al. Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy. Acta Derm Venereol (Stockh) 2008; 88: 484-7.
16. Gibson GE, Daoud MS, Pittelkow MR,. Anti-epiligrin (laminin 5) cicatricial pemphigoid and lung carcinoma: coincidence or association? Br J Dermatol 1997; 137: 780-2. (Pubitemid 27496198)
17. Lenz P, Hsu R, Yee C, et al. [Cicatricial pemphigoid with autoantibodies to laminin 5 (epiligrin) in a patient with metastatic endometrial carcinoma]. Hautarzt 1998; 49: 31-5. (Pubitemid 28083588)
18. Yancey KB, Kirtschig G, Yee C, et al. Studies of patients with anti-epiligrin cicatricial pemphigoid. J Dermatol 1995; 22: 829-35. (Pubitemid 26010658)
19. Egan CA, Yancey KB,. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 2000; 10: 585-9. (Pubitemid 32039420)
20. Lazarova Z, Sitaru C, Zillikens D, et al. Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol 2004; 51: 886-92. (Pubitemid 39593002)
21. Vodegel RM, Jonkman MF, Pas HH, et al. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004; 151: 112-18. (Pubitemid 39061287)
22. Pas HH, Kloosterhuis GJ, Heeres K, et al. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol 1997; 108: 423-9. (Pubitemid 27148276)
23. Kirtschig G, Marinkovich MP, Burgeson RE, et al. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995; 105: 543-8.
24. Jonkman MF, Schuur J, Dijk F, et al. Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol 2000; 136: 227-31. (Pubitemid 30090762)
25. Bekou V, Thoma-Uszynski S, Wendler O, et al. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. J Invest Dermatol 2005; 124: 732-40. (Pubitemid 40489500)
26. Wozniak K, Waszczykowska E, Hashimoto T, et al. Anti-epiligrin cicatricial pemphigoid initially limited to the upper respiratory tract. Br J Dermatol 2006; 154: 779-81. (Pubitemid 43374115)
27. Coronella G, Amato L, Berti S, et al. Ocular 'non-scarring' mucous membrane pemphigoid associated with anti-laminin-5 antibodies. Clin Exp Dermatol 2005; 30: 679-81. (Pubitemid 41499828)
28. Whiteside OJ, Martinez Devesa P, Ali I, et al. Mucous membrane pemphigoid: nasal and laryngeal manifestations. J Laryngol Otol 2003; 117: 885-8. (Pubitemid 37468091)
29. Shipman AR, Ali I, Murrell DF, et al. Mucous membrane pemphigoid: are laminin 5 antibodies a risk factor for laryngeal involvement? J Eur Acad Dermatol Venereol 2009; 23: 169-70.
30. Warren LJ, Wojnarowska F, Wilkinson JD,. Oesophageal involvement in cicatricial pemphigoid. Australas J Dermatol 1997; 38: 148-51. (Pubitemid 27382409)
31. Matsushima S, Horiguchi Y, Honda T, et al. A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy. J Dermatol 2004; 31: 10-15. (Pubitemid 38197210)
32. Egan CA, Lazarova Z, Darling TN, et al. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 2001; 357: 1850-1. (Pubitemid 32539120)
33. Dave VK, Vickers CF,. Azathioprine in the treatment of muco-cutaneous pemphigoid. Br J Dermatol 1974; 90: 183-6.
34. Brody HJ, Pirozzi DJ,. Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide. Arch Dermatol 1977; 113: 1598-9. (Pubitemid 8232752)
35. Lazarova Z, Yee C, Lazar J, et al. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit. Clin Immunol 2001; 101: 100-5.
36. Hisamatsu Y, Nishiyama T, Amano S, et al. Usefulness of immunoblotting using purified laminin 5 in the diagnosis of anti-laminin 5 cicatricial pemphigoid. J Dermatol Sci 2003; 33: 113-19. (Pubitemid 37315904)
37. Fujimoto W, Toi Y, Okazaki F, et al. Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5. J Am Acad Dermatol 1999; 40: 637-9. (Pubitemid 29153199)
38. Endo Y, Kato M, Kitoh A, et al. Pemphigoid without mucosal involvement showing autoantibodies against laminin-332 gamma2 subunit. Br J Dermatol 2010; 163: 1120-2.
39. Dainichi T, Koga H, Tsuji T, et al. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol 2010; 37: 231-8.
40. Dilling A, Rose C, Hashimoto T, et al. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 2007; 34: 1-8. (Pubitemid 46005950)
41. De Jong MC, Bruins S, Heeres K, et al. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol 1996; 132: 151-7. (Pubitemid 26058503)
42. Wozniak K, Kazama T, Kowalewski C,. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003; 139: 1007-11. (Pubitemid 36994825)
43. Vodegel RM, Kiss M, De Jong MCJM, et al. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Eur J Dermatol 1998; 8: 83-5. (Pubitemid 28149838)